ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,999.30
-0.23%
S&P ASX All Technology
3,160.00
-0.16%
Brent Oil
83.39
-1.13%
US Dollar vs AUD
1.48724
0.59%
Bitcoin
64,508.46
-0.53%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vericel Corporation (VCEL)

  7. Vericel Corporation (VCEL) News

VCEL

Vericel (VCEL)

Vericel Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VCEL
DateTimeSourceHeadlineSymbolCompany
01/05/201206:00GlobeNewswire Inc.Aastrom to Hold Annual Meeting of Shareholders on May 3, 2012NASDAQ:VCELVericel Corporation
17/04/201206:11Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:VCELVericel Corporation
10/04/201222:20MarketwiredJOBS Act Allows Emerging Biotech Companies to Focus Funding on ResearchNASDAQ:VCELVericel Corporation
10/04/201200:45MarketwiredExclusive Video Q&A With Timothy M. Mayleben, CEO of Aastrom BiosciencesNASDAQ:VCELVericel Corporation
07/04/201207:03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:VCELVericel Corporation
05/04/201223:00GlobeNewswire Inc.Final Results from RESTORE-CLI Phase 2b Clinical Trial for Ixmyelocel-T in Treatment of Critical Limb Ischemia Published in t...NASDAQ:VCELVericel Corporation
02/04/201220:02Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:VCELVericel Corporation
29/03/201207:30GlobeNewswire Inc.Aastrom to Present at the Needham & Company 11th Annual Healthcare ConferenceNASDAQ:VCELVericel Corporation
27/03/201200:15GlobeNewswire Inc.Aastrom Biosciences to Present New Findings on Atheroprotective Effects of Ixmyelocel-T at Keystone Symposia on AtherosclerosisNASDAQ:VCELVericel Corporation
24/03/201207:21Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)NASDAQ:VCELVericel Corporation
23/03/201208:15Edgar (US Regulatory)-Seperately filed delaying amendment under Securities Act Rule 473 to delay effectiveness of a 1933 Act reg. statement (DEL AM)NASDAQ:VCELVericel Corporation
20/03/201208:30Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)NASDAQ:VCELVericel Corporation
16/03/201207:01Edgar (US Regulatory)Annual Report (10-K)NASDAQ:VCELVericel Corporation
15/03/201200:21GlobeNewswire Inc.Aastrom Biosciences Appoints Dr. LaVonne Lang as Head of Regulatory AffairsNASDAQ:VCELVericel Corporation
13/03/201207:11GlobeNewswire Inc.Aastrom Biosciences Reports Fourth Quarter and Year-End 2011 Financial ResultsNASDAQ:VCELVericel Corporation
13/03/201200:00GlobeNewswire Inc.Aastrom to Present at 24th Annual ROTH Capital ConferenceNASDAQ:VCELVericel Corporation
10/03/201208:46Edgar (US Regulatory)Current report filing (8-K)NASDAQ:VCELVericel Corporation
10/03/201203:10Edgar (US Regulatory)Current report filing (8-K)NASDAQ:VCELVericel Corporation
10/03/201203:00GlobeNewswire Inc.Aastrom Biosciences Completes $40 Million FinancingNASDAQ:VCELVericel Corporation
10/03/201203:00GlobeNewswire Inc.Webcast Alert: Aastrom to Report Fourth Quarter and Year-End 2011 Operating Results on Monday, March 12, 2012NASDAQ:VCELVericel Corporation
06/03/201200:20MarketwiredBioTime and Aastrom Biosciences -- Stem Cell Research Making BreakthroughsNASDAQ:VCELVericel Corporation
01/03/201208:30GlobeNewswire Inc.Aastrom Biosciences Announces Initiation of Patient Enrollment in REVIVE Phase 3 Clinical Trial of Ixmyelocel-TNASDAQ:VCELVericel Corporation
25/01/201200:20MarketwiredBreakthrough Therapy Using Cord Blood Banking Driving Stem Cell IndustryNASDAQ:VCELVericel Corporation
10/01/201200:20MarketwiredStem Cell Therapy From Aastrom Biosciences and Cytori Therapeutics Looks to Gain Ground in 2012NASDAQ:VCELVericel Corporation
07/01/201209:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VCELVericel Corporation
23/12/201103:30Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:VCELVericel Corporation
23/11/201109:25Edgar (US Regulatory)Current report filing (8-K)NASDAQ:VCELVericel Corporation
23/11/201108:05GlobeNewswire Inc.Aastrom Biosciences to Present at Piper Jaffray 23rd Annual Health Care Conference in New York CityNASDAQ:VCELVericel Corporation
17/11/201100:16MarketwiredBreakthrough Stem Cell Therapy From Aastrom Biosciences and NeoStem Begins to Gain GroundNASDAQ:VCELVericel Corporation
15/11/201108:03Edgar (US Regulatory)Current report filing (8-K)NASDAQ:VCELVericel Corporation
 Showing the most relevant articles for your search:NASDAQ:VCEL

Your Recent History

BIT
S31831
Societe Generale Effekten
BIT
SRSA
Exchange Trading Funds
AMEX
SZB
Southfirst Bkshr
BIT
P1Y201
NLBNPIT1Y201 20240920 3.2
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved